Customize Your GlobalSpec Experience

Job Function

Industry

Select Your Free Newsletters

Specs & Techs Engineering Newsletter Engineering in Motion: Video Newsletter

Industry Newsletters

Select Your Free Product Alerts

Pump Applications Motors Plastics and Polymer Products Semiconductors

Finish!

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

HHS - 21 CFR PART 212

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

active, Most Current

Organization:	HHS
Publication Date:	1 April 2016
Status:	active
Page Count:	10

Document History

21 CFR PART 212

April 1, 2022

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2021

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2019

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2018

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2017

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2016

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2015

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.

21 CFR PART 212

April 1, 2014

CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

A description is not available for this item.